Drugs / Midazolam Syrup
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05504876 | Nov → Dec 2022 | — | Sunshine Lake Pharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Midazolam Syrup | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05504876 ↗ |
| Route | Oral | “Administered Midazolam Syrup 5 mg orally once daily in fed state;” NCT05504876 ↗ |